- SEATTLE–(BUSINESS WIRE)–LSBio (LSBio™), pleased to announce its acquisition of Redcar, UK-based Absolute Antibody, Ltd. and its sister company Kerafast
- Terms of the transaction were not disclosed
- LSBio also provides IHC-validated reagent antibodies and services to the global community of academic, pharmaceutical, and biotech researchers
- The Company has built a catalog of more than 750,000 reagent antibodies, assay kits, proteins, and biochemicals, and its acquisition of Absolute Antibody and Kerafast
- The new acquisition combines a strong recombinant antibody portfolio with LSBio’s expertise in application-specific validation to make sequence-defined
- The acquisition marks the latest investment by LSBio to rapidly build its product portfolio
